Cargando…
Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
BACKGROUND: Myopia has recently emerged as a significant threat to global public health. The high and pathological myopia in children and adolescents could result in irreversible damage to eye tissues and severe impairment of visual function without timely control. Posterior scleral reinforcement (P...
Autores principales: | Yan, Chunxiao, Zhao, Fangkun, Gao, Shang, Liu, Xiaoyu, Yu, Taorui, Mu, Yanan, Zhang, Lijun, Xu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683125/ https://www.ncbi.nlm.nih.gov/pubmed/38012561 http://dx.doi.org/10.1186/s12886-023-03211-w |
Ejemplares similares
-
The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023) -
Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022) -
Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023) -
Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021) -
Overnight orthokeratology is comparable with atropine in controlling myopia
por: Lin, Hui-Ju, et al.
Publicado: (2014)